GPT and laryngotracheoesophageal cleft: Of the 360 patients analyzed, 195 patients could be grouped into one of these three groups (Group-1: 48 patients with low HBV DNA and ALT persistently within ULN; Group-2: 74 patients with high HBV DNA and ALT levels above ULN, and Group-3: 73 patients with LC and HCC) (Table 1).